Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 4.54% | $238.89K | ― | ― | ― | |
| AstraZeneca | 4.23% | $222.94K | £220.41B | 29.45% | 80 Outperform | |
| TSMC | 4.20% | $221.33K | $1.38T | 52.62% | 81 Outperform | |
| Samsung Electronics | 3.63% | $191.38K | $615.73B | 160.69% | ― | |
| Mitsubishi Electric | 3.36% | $177.19K | ¥9.95T | 68.10% | 72 Outperform | |
| SSE | 3.23% | $170.37K | £27.76B | 50.10% | 74 Outperform | |
| Ebara | 3.14% | $165.49K | ¥2.04T | 91.58% | 60 Neutral | |
| BP p.l.c. | 3.04% | $160.27K | £65.04B | 0.12% | 71 Outperform | |
| Royal Bank Of Canada | 2.82% | $148.55K | $236.46B | 43.18% | 75 Outperform | |
| ING GROEP | 2.71% | $142.94K | €69.15B | 59.99% | 61 Neutral |